Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy

In the evolving immune-oncology landscape, numerous patients with cancer are constantly treated with immune checkpoint inhibitors (ICPIs) but among them, only sporadic cases with pre-existing hepatitis B virus (HBV) and hepatitis C virus (HCV) are recorded. Despite the global dissemination of HBV an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziogas, Dimitrios C, Kostantinou, Frosso, Cholongitas, Evangelos, Anastasopoulou, Amalia, Diamantopoulos, Panagiotis, Haanen, John, Gogas, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570225/
https://www.ncbi.nlm.nih.gov/pubmed/33067316
http://dx.doi.org/10.1136/jitc-2020-000943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570225/
https://www.ncbi.nlm.nih.gov/pubmed/33067316
http://dx.doi.org/10.1136/jitc-2020-000943

Ejemplares similares